Randomised trials in surgery: problems and possible solutions
By P. Mcculloch, I. Taylor, M. Sasako, B. Lovett, D. Griffin. British medical journal, 2002
756 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Oncology, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/23d6d1166a03d5580c8874c7281823c413a2c467
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Oncology
In Statistics and Probability
- David Moher
- Douglas G. Altman
- K. F. Schulz
- I. Boutron
- Philippe Ravaud
- Xian-Tao Zeng
- H. Weng
- Di Huang
Citations in the corpus
- Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. (2008, background): “Eligibility criteria should be justified, because they will influence the applicability of the trial results (58, 73, 74).”
- Surgical data science – from concepts toward clinical translation (2020, background): “Furthermore, randomized controlled trials (RCTs) to evaluate surgical interventions are difficult to perform (McCulloch et al., 2002).”
- Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? (2020, background): “In clinical research, RCT is not always feasible [35]; therefore, non-randomized design remains considerable.”
- The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review (2015, background): “In clinical research, especially in surgery, RCT is not always feasible (25).”